National Pharmaceuticals Pricing Policy (NPPP), 2012 prescribes the guidelines for regulation of prices of drugs. The key principles of price regulation are (i) essentiality of drugs (ii) control of prices of formulations and (iii) MarketBased Pricing. Based on NPPP, 2012 and subsequent Drugs (Prices Control) Order, 2013 (DPCO, 2013), National Pharmaceutical Pricing Authority (NPPA) under the Department of Pharmaceuticals fixes the ceiling price of scheduled drugs specified in the first schedule of the DPCO, 2013 and monitors the prices of non-scheduled drugs. 

NPPA has fixed the ceiling prices of scheduled drugs, including the essential medicines used for treatment of cancer, diabetes and HIV as well as heart and kidney diseases. Further, NPPA has put a cap on Trade Margin of 42 select non-scheduled anti-cancer medicines under ‘Trade Margin Rationalization (TMR)’ Approach resulting in reduction up to 90% of Maximum Retail Price (MRP) of526 brands of these medicines.

NPPA has also brought 106 non-scheduled anti-diabetic and cardiovascular drugs under price control by invoking extraordinary powers in public interest.The total annual savings on account of revision of ceiling prices of medicines under National List of Essential Medicines (NLEM), price control of anti-diabetic & cardiovascular, fixation of ceiling price of stents, knee implants and capping of TMR on anti-cancer are estimated to the tune of Rs. 12,500 crore. NPPA monitors the ceiling price of the scheduled formulations to ensure that the MRP of such formulations are within the range of ceiling price and monitors non-scheduled formulations to ensure that their MRP does not increase by more than 10% during the preceding twelve months. The details of retail/ceiling prices fixed/revised by NPPA are available on NPPA’s website www.nppaindia.nic.in.

The details of the formulations for which price have been fixed by NPPA in the last 3 years are as follows:

S. No	Type	2018-19	2019-20	2020-21	2021-22 (till 31st  July 2021)
1.	Ceiling Price	5	7	12	1
2.	Retail Price	329	256	321	84
3.	Ceiling price for Pharmaceutical Purchase Policy (Recommendation)	-	105	57	-
4.	TMR	42 (Anti Cancer drugs)	-	-	6 (Medical Devices)

 

Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), till 04.08.2021, about 8,004 Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) are open across the country to provide generic medicines at cheaper rates to the citizens. Till 04.08.2021, about 236 PMBJKs are open in the State of Chhattisgarh.  State/UT wise list of PMBJKs is as:

State/UT wise list of PMBJK's functioning across the country as on 04.08.2021
Sl. No.	Name of the State/UT	No. of PMBJK functional
1	Andaman & Nicobar	2
2	Andhra Pradesh	180
3	Arunachal Pradesh	28
4	Assam	83
5	Bihar	244
6	Chandigarh	7
7	Chhattisgarh	236
8	Delhi	333
9	Goa	9
10	Gujarat	533
11	Haryana	215
12	Himachal Pradesh	61
13	Jammu And Kashmir	100
14	Jharkhand	73
15	Karnataka	916
16	Kerala	825
17	Ladakh	3
18	Lakshadweep *	0
19	Madhya Pradesh	223
20	Maharashtra	592
21	Manipur	32
22	Meghalaya	14
23	Mizoram	22
24	Nagaland	16
25	Odisha	302
26	Puducherry	16
27	Punjab	285
28	Rajasthan	125
29	Sikkim	3
30	Tamil Nadu	822
31	Telangana	153
32	DNH & D&D	35
33	Tripura	24
34	Uttar Pradesh	1114
35	Uttarakhand	205
36	West Bengal	173
Grand Total		8004
* Medicines are directly supplied to the administration of UT of Lakshadweep

 

This information was given by the Minister of Health & Family Welfare and Chemicals & Fertilizers, Shri Mansukh Mandaviya in a written reply in Lok Sabha today.

 

*******

MV/AL

(Release ID: 1744388)